The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA vaccines to prevent SARS-CoV-2 infection.

RFK Jr. pledged not to upend US vaccine system, but big changes are underway. It's unclear which shots will be available.

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

Tesla's Chinese rival Xiaomi announced its electric SUV set to compete with Tesla's Model Y will be launched Thursday. TXNM ...

Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID ...

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...

Novavax Inc. jumped after US regulators fully approved its Covid vaccine, easing investors’ concerns after the clearance was ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval. HealthDay News — Novavax’s COVID-19 vaccine could soon receive full ...

Novavax’s COVID-19 vaccine could soon receive full approval from the US Food and Drug Administration (FDA). HealthDay News — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S.